Table 2.
Timepoint |
Study period | |||||||||||
Enrolment | Allocation | Post allocation | Post intervention | |||||||||
Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 7 | Week 8 | Week 9 | 9 months | |||
Enrolment | ||||||||||||
Eligibility screen | X | |||||||||||
Informed consent | X | |||||||||||
Allocation | X | |||||||||||
Interventions | ||||||||||||
Immediate access to MindOnLine | ||||||||||||
Waitlist group | ||||||||||||
Assessments (both groups) | ||||||||||||
Demographic characteristics | X | |||||||||||
FCRI 18 | X | X | X | |||||||||
GAD-7 20 | X | X | X | |||||||||
PHQ-9 19 | X | X | X | |||||||||
CAMS-R 22 | X | X | X | |||||||||
AQoL-4D 21 | X | X | X | |||||||||
Mindfulness experience | X | X | X | |||||||||
Resource use | X | X | X | |||||||||
COVID-19 measures | X | X | X | |||||||||
Assessments (intervention group only) | ||||||||||||
Adherence tracking and meditation log | X | X | X | X | X | X | X | X | X | X | ||
Programme satisfaction | X | X |
AQOL-4D, Assessment of Quality of Life; CAMS-R, Cognitive and Affective Mindfulness Scale-Revised; FCRI, Fear of Cancer Recurrence Inventory; GAD-7, Generalised Anxiety Disorder; PHQ-9, Patient Health Questionnaire.